SOX2 and neoplasm: As a large body of published studies demonstrates a correlation between high expression levels and poor prognosis, an elevated incidence of recurrence, and/or invasive and metastatic capacity of tumor cells, SOX2 has been considered as a potential therapeutic drug target [36].